Copyright Reports & Markets. All rights reserved.

Global Cytotoxicity Testing Services Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Cytotoxicity Testing Services by Type
    • 1.3.1 Overview: Global Cytotoxicity Testing Services Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global Cytotoxicity Testing Services Consumption Value Market Share by Type in 2025
    • 1.3.3 Elution Testing Method
    • 1.3.4 Agar Overlay Method
    • 1.3.5 Direct Contact Method
    • 1.3.6 MTT Assay Method
    • 1.3.7 Others
  • 1.4 Global Cytotoxicity Testing Services Market by Application
    • 1.4.1 Overview: Global Cytotoxicity Testing Services Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Drug
    • 1.4.3 Medical Instruments
    • 1.4.4 Cosmetics and Personal Care
    • 1.4.5 Others
  • 1.5 Global Cytotoxicity Testing Services Market Size & Forecast
  • 1.6 Global Cytotoxicity Testing Services Market Size and Forecast by Region
    • 1.6.1 Global Cytotoxicity Testing Services Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global Cytotoxicity Testing Services Market Size by Region, (2021-2032)
    • 1.6.3 North America Cytotoxicity Testing Services Market Size and Prospect (2021-2032)
    • 1.6.4 Europe Cytotoxicity Testing Services Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific Cytotoxicity Testing Services Market Size and Prospect (2021-2032)
    • 1.6.6 South America Cytotoxicity Testing Services Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa Cytotoxicity Testing Services Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 UL
    • 2.1.1 UL Details
    • 2.1.2 UL Major Business
    • 2.1.3 UL Cytotoxicity Testing Services Product and Solutions
    • 2.1.4 UL Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 UL Recent Developments and Future Plans
  • 2.2 SGS
    • 2.2.1 SGS Details
    • 2.2.2 SGS Major Business
    • 2.2.3 SGS Cytotoxicity Testing Services Product and Solutions
    • 2.2.4 SGS Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 SGS Recent Developments and Future Plans
  • 2.3 iuvo BioScience
    • 2.3.1 iuvo BioScience Details
    • 2.3.2 iuvo BioScience Major Business
    • 2.3.3 iuvo BioScience Cytotoxicity Testing Services Product and Solutions
    • 2.3.4 iuvo BioScience Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 iuvo BioScience Recent Developments and Future Plans
  • 2.4 Sartorius
    • 2.4.1 Sartorius Details
    • 2.4.2 Sartorius Major Business
    • 2.4.3 Sartorius Cytotoxicity Testing Services Product and Solutions
    • 2.4.4 Sartorius Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Sartorius Recent Developments and Future Plans
  • 2.5 Eurofins Scientific
    • 2.5.1 Eurofins Scientific Details
    • 2.5.2 Eurofins Scientific Major Business
    • 2.5.3 Eurofins Scientific Cytotoxicity Testing Services Product and Solutions
    • 2.5.4 Eurofins Scientific Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Eurofins Scientific Recent Developments and Future Plans
  • 2.6 TÜV SÜD
    • 2.6.1 TÜV SÜD Details
    • 2.6.2 TÜV SÜD Major Business
    • 2.6.3 TÜV SÜD Cytotoxicity Testing Services Product and Solutions
    • 2.6.4 TÜV SÜD Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 TÜV SÜD Recent Developments and Future Plans
  • 2.7 Nelson Labs
    • 2.7.1 Nelson Labs Details
    • 2.7.2 Nelson Labs Major Business
    • 2.7.3 Nelson Labs Cytotoxicity Testing Services Product and Solutions
    • 2.7.4 Nelson Labs Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Nelson Labs Recent Developments and Future Plans
  • 2.8 Pacific BioLabs
    • 2.8.1 Pacific BioLabs Details
    • 2.8.2 Pacific BioLabs Major Business
    • 2.8.3 Pacific BioLabs Cytotoxicity Testing Services Product and Solutions
    • 2.8.4 Pacific BioLabs Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Pacific BioLabs Recent Developments and Future Plans
  • 2.9 Emery Pharma
    • 2.9.1 Emery Pharma Details
    • 2.9.2 Emery Pharma Major Business
    • 2.9.3 Emery Pharma Cytotoxicity Testing Services Product and Solutions
    • 2.9.4 Emery Pharma Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Emery Pharma Recent Developments and Future Plans
  • 2.10 UFAG Laboratorien AG
    • 2.10.1 UFAG Laboratorien AG Details
    • 2.10.2 UFAG Laboratorien AG Major Business
    • 2.10.3 UFAG Laboratorien AG Cytotoxicity Testing Services Product and Solutions
    • 2.10.4 UFAG Laboratorien AG Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 UFAG Laboratorien AG Recent Developments and Future Plans
  • 2.11 NorthEast BioLab
    • 2.11.1 NorthEast BioLab Details
    • 2.11.2 NorthEast BioLab Major Business
    • 2.11.3 NorthEast BioLab Cytotoxicity Testing Services Product and Solutions
    • 2.11.4 NorthEast BioLab Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 NorthEast BioLab Recent Developments and Future Plans
  • 2.12 Biosafe Ltd
    • 2.12.1 Biosafe Ltd Details
    • 2.12.2 Biosafe Ltd Major Business
    • 2.12.3 Biosafe Ltd Cytotoxicity Testing Services Product and Solutions
    • 2.12.4 Biosafe Ltd Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Biosafe Ltd Recent Developments and Future Plans
  • 2.13 Creative Bioarray
    • 2.13.1 Creative Bioarray Details
    • 2.13.2 Creative Bioarray Major Business
    • 2.13.3 Creative Bioarray Cytotoxicity Testing Services Product and Solutions
    • 2.13.4 Creative Bioarray Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.13.5 Creative Bioarray Recent Developments and Future Plans
  • 2.14 Evercyte
    • 2.14.1 Evercyte Details
    • 2.14.2 Evercyte Major Business
    • 2.14.3 Evercyte Cytotoxicity Testing Services Product and Solutions
    • 2.14.4 Evercyte Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.14.5 Evercyte Recent Developments and Future Plans
  • 2.15 IONTOX
    • 2.15.1 IONTOX Details
    • 2.15.2 IONTOX Major Business
    • 2.15.3 IONTOX Cytotoxicity Testing Services Product and Solutions
    • 2.15.4 IONTOX Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.15.5 IONTOX Recent Developments and Future Plans
  • 2.16 Applied StemCell
    • 2.16.1 Applied StemCell Details
    • 2.16.2 Applied StemCell Major Business
    • 2.16.3 Applied StemCell Cytotoxicity Testing Services Product and Solutions
    • 2.16.4 Applied StemCell Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.16.5 Applied StemCell Recent Developments and Future Plans
  • 2.17 Xenometrix AG
    • 2.17.1 Xenometrix AG Details
    • 2.17.2 Xenometrix AG Major Business
    • 2.17.3 Xenometrix AG Cytotoxicity Testing Services Product and Solutions
    • 2.17.4 Xenometrix AG Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.17.5 Xenometrix AG Recent Developments and Future Plans
  • 2.18 Medicilon
    • 2.18.1 Medicilon Details
    • 2.18.2 Medicilon Major Business
    • 2.18.3 Medicilon Cytotoxicity Testing Services Product and Solutions
    • 2.18.4 Medicilon Cytotoxicity Testing Services Revenue, Gross Margin and Market Share (2021-2026)
    • 2.18.5 Medicilon Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Cytotoxicity Testing Services Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of Cytotoxicity Testing Services by Company Revenue
    • 3.2.2 Top 3 Cytotoxicity Testing Services Players Market Share in 2025
    • 3.2.3 Top 6 Cytotoxicity Testing Services Players Market Share in 2025
  • 3.3 Cytotoxicity Testing Services Market: Overall Company Footprint Analysis
    • 3.3.1 Cytotoxicity Testing Services Market: Region Footprint
    • 3.3.2 Cytotoxicity Testing Services Market: Company Product Type Footprint
    • 3.3.3 Cytotoxicity Testing Services Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Cytotoxicity Testing Services Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global Cytotoxicity Testing Services Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global Cytotoxicity Testing Services Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global Cytotoxicity Testing Services Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America Cytotoxicity Testing Services Consumption Value by Type (2021-2032)
  • 6.2 North America Cytotoxicity Testing Services Market Size by Application (2021-2032)
  • 6.3 North America Cytotoxicity Testing Services Market Size by Country
    • 6.3.1 North America Cytotoxicity Testing Services Consumption Value by Country (2021-2032)
    • 6.3.2 United States Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 6.3.3 Canada Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico Cytotoxicity Testing Services Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe Cytotoxicity Testing Services Consumption Value by Type (2021-2032)
  • 7.2 Europe Cytotoxicity Testing Services Consumption Value by Application (2021-2032)
  • 7.3 Europe Cytotoxicity Testing Services Market Size by Country
    • 7.3.1 Europe Cytotoxicity Testing Services Consumption Value by Country (2021-2032)
    • 7.3.2 Germany Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 7.3.3 France Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 7.3.5 Russia Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 7.3.6 Italy Cytotoxicity Testing Services Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific Cytotoxicity Testing Services Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific Cytotoxicity Testing Services Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific Cytotoxicity Testing Services Market Size by Region
    • 8.3.1 Asia-Pacific Cytotoxicity Testing Services Consumption Value by Region (2021-2032)
    • 8.3.2 China Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 8.3.3 Japan Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 8.3.5 India Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 8.3.7 Australia Cytotoxicity Testing Services Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America Cytotoxicity Testing Services Consumption Value by Type (2021-2032)
  • 9.2 South America Cytotoxicity Testing Services Consumption Value by Application (2021-2032)
  • 9.3 South America Cytotoxicity Testing Services Market Size by Country
    • 9.3.1 South America Cytotoxicity Testing Services Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina Cytotoxicity Testing Services Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa Cytotoxicity Testing Services Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa Cytotoxicity Testing Services Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa Cytotoxicity Testing Services Market Size by Country
    • 10.3.1 Middle East & Africa Cytotoxicity Testing Services Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia Cytotoxicity Testing Services Market Size and Forecast (2021-2032)
    • 10.3.4 UAE Cytotoxicity Testing Services Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 Cytotoxicity Testing Services Market Drivers
  • 11.2 Cytotoxicity Testing Services Market Restraints
  • 11.3 Cytotoxicity Testing Services Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Cytotoxicity Testing Services Industry Chain
  • 12.2 Cytotoxicity Testing Services Upstream Analysis
  • 12.3 Cytotoxicity Testing Services Midstream Analysis
  • 12.4 Cytotoxicity Testing Services Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cytotoxicity Testing Services market size was valued at US$ 167 million in 2025 and is forecast to a readjusted size of US$ 250 million by 2032 with a CAGR of 6.0% during review period.
    Cytotoxicity testing services involve the evaluation of the toxicity of substances (such as chemicals, drugs, biomaterials, or medical devices) on cells. These services are crucial in various fields including pharmaceuticals, cosmetics, biomaterials research, and environmental science. The main goal is to determine whether a test substance has the potential to damage or kill cells, which can provide important information about its safety and biocompatibility.
    This report is a detailed and comprehensive analysis for global Cytotoxicity Testing Services market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Cytotoxicity Testing Services market size and forecasts, in consumption value ($ Million), 2021-2032
    Global Cytotoxicity Testing Services market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global Cytotoxicity Testing Services market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global Cytotoxicity Testing Services market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Cytotoxicity Testing Services
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Cytotoxicity Testing Services market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UL, SGS, iuvo BioScience, Sartorius, Eurofins Scientific, TÜV SÜD, Nelson Labs, Pacific BioLabs, Emery Pharma, UFAG Laboratorien AG, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Cytotoxicity Testing Services market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Elution Testing Method
    Agar Overlay Method
    Direct Contact Method
    MTT Assay Method
    Others
    Market segment by Application
    Drug
    Medical Instruments
    Cosmetics and Personal Care
    Others
    Market segment by players, this report covers
    UL
    SGS
    iuvo BioScience
    Sartorius
    Eurofins Scientific
    TÜV SÜD
    Nelson Labs
    Pacific BioLabs
    Emery Pharma
    UFAG Laboratorien AG
    NorthEast BioLab
    Biosafe Ltd
    Creative Bioarray
    Evercyte
    IONTOX
    Applied StemCell
    Xenometrix AG
    Medicilon
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Cytotoxicity Testing Services product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Cytotoxicity Testing Services, with revenue, gross margin, and global market share of Cytotoxicity Testing Services from 2021 to 2026.
    Chapter 3, the Cytotoxicity Testing Services competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Cytotoxicity Testing Services market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Cytotoxicity Testing Services.
    Chapter 13, to describe Cytotoxicity Testing Services research findings and conclusion.

    Buy now